|
EXP001301
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-BP100
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001302
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-OEP34 (CTP) + BP100 (CPP)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001303
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-OEP34 (CTP) + BP100 (CPP)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001304
|
Non-transgenic Gene Modulation via Spray Delivery of Nucleic Acid/Peptide Compl…
|
2022 |
KH9-OEP34 (CTP) + BP100 (CPP)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001305
|
Cell penetrating peptide-mediated systemic siRNA delivery to the liver
|
2011 |
Octaarginine (R8)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP001306
|
Cell penetrating peptide-mediated systemic siRNA delivery to the liver
|
2011 |
Octaarginine (R8)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP001307
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001308
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001309
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001310
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001311
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001312
|
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and thei…
|
2012 |
PepFect 14 (PF14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001313
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
TAT
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001314
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
dTAT (double TAT)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001315
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
dTAT (double TAT)
|
siRNA
|
no |
|
|
yes |
no |
|
EXP001316
|
Calcium condensed cell penetrating peptide complexes offer highly efficient, lo…
|
2012 |
dTAT (double TAT)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001317
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001318
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001319
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP001320
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA
|
no |
|
|
yes |
no |
|
EXP001321
|
Mitochondrial transgene expression via an artificial mitochondrial DNA vector i…
|
2018 |
KALA
|
pDNA
|
no |
|
|
yes |
no |
|
EXP001322
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001323
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001324
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001325
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP001326
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP001327
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP001328
|
Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ul…
|
2015 |
Penetratin-derived CPP
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP001329
|
Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Pept…
|
2017 |
N/A (DNA tetrahedron vector; no peptide carrier)
|
ASO
|
no |
yes |
|
no |
no |
|
EXP001330
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT-A1 (VEGFR1-targeted TAT)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001331
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT-A1 (VEGFR1-targeted TAT)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001332
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT (HIV-1 Tat CPP)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001333
|
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selecti…
|
2013 |
TAT (HIV-1 Tat CPP)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001334
|
Improving the efficacy of liposome-mediated vascular gene therapy via lipid sur…
|
2017 |
Octaarginine (R8)
|
siRNA
|
yes |
|
|
no |
no |
|
EXP001335
|
Improving the efficacy of liposome-mediated vascular gene therapy via lipid sur…
|
2017 |
Octaarginine (R8)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001336
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
TAT-ABE8e (covalent CPP fusion)
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001337
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
CPP5-ABE8e (covalent CPP fusion)
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001338
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
ANTP-ABE8e (covalent CPP fusion)
|
sgRNA
|
no |
yes |
|
no |
no |
|
EXP001339
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
CPP5-ABE8e (covalent CPP fusion)
|
sgRNA
|
no |
|
|
yes |
yes |
|
EXP001340
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
TAT-ABE8e (covalent CPP fusion)
|
sgRNA
|
no |
|
|
yes |
yes |
|
EXP001341
|
Safer and efficient base editing and prime editing via ribonucleoproteins deliv…
|
2025 |
ANTP-ABE8e (covalent CPP fusion)
|
sgRNA
|
no |
|
|
yes |
yes |
|
EXP001342
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001343
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001344
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001345
|
Super-resolution Imaging of Structure, Molecular Composition, and Stability of …
|
2019 |
L-nona-arginine (R9)
|
mRNA
|
yes |
no |
|
no |
no |
|
EXP001346
|
Iron oxide nanoparticles decorated with functional peptides for a targeted siRN…
|
2022 |
CTX-R10 (chlorotoxin + deca-arginine)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001347
|
Iron oxide nanoparticles decorated with functional peptides for a targeted siRN…
|
2022 |
CTX-R10 (chlorotoxin + deca-arginine)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001348
|
Chaperonin–Dendrimer Conjugates for siRNA Delivery
|
2016 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001349
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
SRCRP2-11 (DMBT1-derived CPP)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001350
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
SRCRP2-11-R (DMBT1-derived CPP mutant)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001351
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
TAT (control CPP)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001352
|
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
|
2017 |
CADY (control CPP)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001353
|
Cyclic peptide-based nanostructures as efficient siRNA carriers
|
2018 |
CP I
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001354
|
Cyclic peptide-based nanostructures as efficient siRNA carriers
|
2018 |
CP II
|
siRNA
|
no |
no |
|
no |
no |
|
EXP001355
|
Cyclic peptide-based nanostructures as efficient siRNA carriers
|
2018 |
CP III
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001356
|
Cyclic peptide-based nanostructures as efficient siRNA carriers
|
2018 |
CP IV
|
siRNA
|
no |
no |
|
no |
no |
|
EXP001357
|
Cyclic peptide-based nanostructures as efficient siRNA carriers
|
2018 |
CP V
|
siRNA
|
no |
no |
|
no |
no |
|
EXP001358
|
Targeted gene silencing in human embryonic stem cells using cell-penetrating pe…
|
2019 |
PepFect 14 (PF14)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001359
|
Targeted gene silencing in human embryonic stem cells using cell-penetrating pe…
|
2019 |
PepFect 14 (PF14)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001360
|
Targeted gene silencing in human embryonic stem cells using cell-penetrating pe…
|
2019 |
PepFect 14 (PF14)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001361
|
Targeted gene silencing in human embryonic stem cells using cell-penetrating pe…
|
2019 |
PepFect 14 (PF14)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001362
|
Targeted gene silencing in human embryonic stem cells using cell-penetrating pe…
|
2019 |
PepFect 14 (PF14)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001363
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
PepFect6 (PF6)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001364
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
PepFect6 (PF6)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001365
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
NickFect70 (NF70)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001366
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
NickFect70 (NF70)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001367
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
PepFect6 (PF6)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001368
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
PepFect6 (PF6)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001369
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
NickFect70 (NF70)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001370
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
NickFect70 (NF70)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP001371
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
PepFect6 (PF6)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001372
|
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosi…
|
2021 |
NickFect70 (NF70)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001373
|
A specific aptamer-cell penetrating peptides complex delivered siRNA efficientl…
|
2016 |
3TAT-DRBD (within STD fusion protein)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001374
|
A specific aptamer-cell penetrating peptides complex delivered siRNA efficientl…
|
2016 |
3TAT-DRBD (within STD fusion protein)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP001375
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001376
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Arginine-rich CPP
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001377
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001378
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001379
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
ASO
|
no |
no |
|
no |
no |
|
EXP001380
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001381
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001382
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001383
|
Interference of hepatitis C virus replication in cell culture by antisense pept…
|
2011 |
Tat48-60
|
ASO
|
no |
no |
|
no |
no |
|
EXP001384
|
Combination of valproic acid and morpholino splice-switching oligonucleotide pr…
|
2017 |
ApoE
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001385
|
Combination of valproic acid and morpholino splice-switching oligonucleotide pr…
|
2017 |
(N)-VPA-ApoE
|
SCO
|
no |
no |
|
no |
no |
|
EXP001386
|
Combination of valproic acid and morpholino splice-switching oligonucleotide pr…
|
2017 |
(O)-VPA-ApoE
|
SCO
|
no |
no |
|
no |
no |
|
EXP001387
|
Combination of valproic acid and morpholino splice-switching oligonucleotide pr…
|
2017 |
ApoE (co-treated with VPA)
|
SCO
|
no |
yes |
|
no |
no |
|
EXP001388
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
Penetratin
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001389
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
Penetratin
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001390
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
SAP(E)
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001391
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
SAP(E)
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001392
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
Transportan
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001393
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
Pep2
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001394
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
MPG
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001395
|
Comparing Agent-Based Delivery of DNA and PNA Forced Intercalation (FIT) Probes…
|
2019 |
Octaarginine (R8)
|
ASO
|
yes |
no |
|
no |
no |
|
EXP001396
|
Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA d…
|
2020 |
NP1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001397
|
Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA d…
|
2020 |
NP1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP001398
|
Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA d…
|
2020 |
NP1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001399
|
Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA d…
|
2020 |
NP1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP001400
|
Therapeutic potential of a cell penetrating peptide (CPP, NP1) mediated siRNA d…
|
2020 |
NP1
|
siRNA
|
yes |
yes |
|
no |
no |